Key Benefits of Revinto Aragwadhadi-Kashaya

• It reduces febrile intensity in acute conditions.
• It modulated blood glucose homeostasis in Prameha.
• It alleviated cutaneous itching sensations in Kandu.
• It accelerates healing progression in non-healing ulcers.
• It balanced skin microbiota in Kusta and other dermal disorders.
• It influenced wound contraction rates in chronic sores.
• It supported metabolic detoxification pathways related to fever.

Product Description of Revinto Aragwadhadi-Kashaya

Revinto Aragwadhadi-Kashaya is an herbal decoction formulated from traditional Ayurvedic preparation. It contain extract from Swertia chirata, Tinospora cordifolia, Azadirachta indica, Terminalia chebula, Emblica officinalis. This was prepared by standardized methods. It had been used for managing Jvara, Prameha, Kandu, Dusta Vrana, Kusta. It exhibited bitter astringent properties. Studies was reported on its phytochemical profile. This decoction involves extraction in water followed by concentration. Ingredient ratio remain consistent lot to lot. It deliver bioactive glycosides, alkaloids and polyphenols. Research described mood regulation effect on gastrointestinal environment. It provided mild cooling sensation.

Key ingredients with descriptions of Revinto Aragwadhadi-Kashaya

• Revinto Aragwadhadi-Kashaya utilizes Swertia chirata bound to polysaccharides, which facilitates metabolism.
• Swertia chirata is a herb that is critical for metabolism, transmission, and mineralization.
• It is a required cofactor for an estimated 50 metabolic pathways.
• Among the processes that require Tinospora cordifolia are transmission and mineralization, as well as metabolism.
• Azadirachta indica status is also important for regulation of metabolism through its effects on the integumentary system.
• Research indicates Terminalia chebula exerts its antioxidant prowess by free radical scavenging.
• Studies suggest Emblica officinalis can help to reduce inflammation, support glucose regulation and ameliorate pruritus.

Key uses of Revinto Aragwadhadi-Kashaya

• Management of acute and chronic febrile conditions.
• Support in regulating blood glucose levels for Prameha.
• Symptomatic relief of Kandu associated with dermatitis.
• Acceleration of healing in Dusta Vrana.
• Supportive care in Kusta and other skin diseases.
• Adjunct for metabolic balance in diabetic complications.
• Reduction of inflammatory markers in chronic ulcers.

How to use Revinto Aragwadhadi-Kashaya

Take 15 ml twice daily before meals with warm water. Shake bottle well. Dosage may adjusted by physician.

Safety information about Revinto Aragwadhadi-Kashaya

Use caution in pregnant women. May interacts with hypoglycemic medications. Avoid in case of known allergy to constituents. Discontinue if rash or gastrointestinal distress occurred. Keep out of reach children. Store at cool dry place away from direct sunlight.

Additional information about Revinto Aragwadhadi-Kashaya

Batch to batch consistency is maintained by strict quality control. Each 100 ml contains standardized extract equivalent to 1.2 g of decoction. No artificial colors or preservatives were added. Shelf life was determined as 24 months from manufacturing date. Packaging used amber glass bottles. Storage condition require below 30°C with humidity not exceeding 60%. Analytical methods include HPLC fingerprinting for marker compounds. Microbial limits were within permissible Ayurvedic pharmacopeia standards. Manufacturing facility was GMP certified. The formula was validated by traditional texts and modern phytochemical studies. This data was compiled from lab analyses. Nutritional values such as carbohydrate content and caloric value were documented. The preparation meet quality standards in organoleptic and physicochemical profiles. Research publications was cited in technical dossier. Laboratory stability studies was monitor potency over time. Materials was sourced from authenticated farms in designated regions. Product code was printed on label. Regulatory compliance was updated as per local guidelines.